Takeda Oncology
Margery Long is an accomplished executive coordinator with extensive experience in supporting senior leadership across various sectors, including oncology and pharmaceuticals. Currently serving as the Executive Coordinator in Global Human Resources, Corporate Communications, and Finance at Takeda Oncology since September 2021, Margery has previously held significant roles such as Executive Assistant to the Senior Vice President of Medical Affairs for North America at Ipsen, and Executive Assistant to the Chief Medical Officer at Momenta Pharmaceuticals. Earlier career highlights include positions at Russell Reynolds Associates and Fidelity Investments, where Margery supported leaders in the Higher Education, Life Sciences, and finance sectors.
This person is not in any teams
This person is not in any offices
Takeda Oncology
21 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.